ACTRN12617000819325已完成未知
Prospective, double-masked, bilateral wear, crossover, dispensing clinical trial to compare the visual performance between a new commercially-available contact lens design which utilise digital zone optics, prototype contact lens designs which utilise higher-order spherical aberrations to increase depth-of-focus and a commercially-available single vision contact lens
Brien Holden Vision Institute0 个研究点目标入组 35 人开始时间: 2017年6月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 40 Years（—）
- 性别
- All
入选标准
- •Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent.
- •Be between 18-40 years old, male or female.
- •Willing to comply with the wearing and clinical trial visit schedule as directed by the Investigator.
- •Have ocular health findings considered to be normal” and which would not prevent the participant from safely wearing contact lenses.
- •Is myopic and correctable to at least 6/12 (20/40) or better in each eye with contact lenses.
- •Be suitable and willing to wear contact lenses.
排除标准
- •Any pre-existing ocular irritation, injury or condition (including infection or disease) of the cornea, conjunctiva or eyelids that would preclude contact lens fitting and safe wearing of contact lenses.
- •Any systemic disease that adversely affects ocular health e.g. diabetes, Graves disease, and auto immune diseases such as ankylosing spondylitis, multiple sclerosis, Sjogrens syndrome and systemic lupus erythematosus. Conditions such as systemic hypertension and arthritis do not automatically exclude prospective participants.
- •Use of or a need for concurrent category S3 and above ocular medication at enrolment and/or during the clinical trial.
- •Use of or a need for any systemic medication or topical medications which may alter normal ocular findings / are known to affect a participant’s ocular health / physiology or contact lens performance either in an adverse or beneficial manner at enrolment and/or during the clinical trial.
- •NB: Systemic antihistamines are allowed on an as needed basis”, provided they are not used prophylactically during the trial and at least 24 hours before the clinical trial product is used.
- •Eye surgery within 12 weeks immediately prior to enrolment for this trial.
- •Previous corneal refractive surgery.
- •Contraindications to contact lens wear.
- •Known allergy or intolerance to ingredients in any of the clinical trial products.
- •Currently enrolled in another clinical trial.
- •Pregnancy*.
- •The Investigator may, at his/her discretion, exclude anyone who they believe may not be able to fulfil the clinical trial requirements or it is believed to be in the participant’s best interests.
- •*Formal testing of pregnancy is not required. A participant’s verbal report is sufficient.
研究者
相似试验
已完成
不适用
Dispensing study to assess the visual performance of optimised prototype contact lensesMyopiaPresbyopiaACTRN12617000247370Brien Holden Vision Pty Ltd120
已完成
不适用
Dispensing study to assess the visual performance of optimised prototype contact lensesEye - Normal eye development and functionPresbyopiaACTRN12615000652572Brien Holden Vision Pty Ltd150
已完成
不适用
Clinical trial to assess the visual performance of prototype contact lenses for astigmatismAstigmatismACTRN12615001337561Brien Holden Vision Pty Ltd35
撤回
不适用
A short-term evaluation of the accommodative responses of 6 contact lenses for myopia control and a control lens.Ocular AccommodationEye - Diseases / disorders of the eyeMyopiaACTRN12618001790235Brien Holden Vision Institute57
已完成
不适用
Visual performance of prototype contact lens designs.Eye - Normal eye development and functionMyopiaPresbyopiaACTRN12614000776606Brien Holden Vision Pty Ltd60